Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

Thermo Fisher Scientific shares rose Wednesday after the lab equipment and life science solutions firm reported first-quarter ...

Thermo Fisher cut its 2025 EPS and revenue outlook due to tariffs and U.S. policy changes, expecting a $400 million sales hit ...

Company management said they expect the tariff battle with China to cause weakening of $375 million in adjusted operating income.

Goldman Sachs analyst Matthew Sykes lowered the firm’s price target on Thermo Fisher (TMO) to $610 from $670 but keeps a Buy rating on the ...

Thermo Fisher CEO Marc Casper noted strong performance in Q1 2025, delivering $10.36 billion in revenue. Adjusted EPS grew 1% to $5.15. Adjusted operating income was $2.27 billion, with an adjusted ...

Consensus $23.25. Expands FY25 revenue view to $43.3B-$44.2B from $43.5B-$44B, consensus $43.83B. Guidance taken from Q1 earnings conference ...

Thermo Fisher Scientific Inc. ( NYSE: TMO) Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Rafael Tejada - Vice President, Investor Relations Marc Casper - Chairman, President & Chief ...

Shares of Thermo Fisher Scientific Inc. (TMO) were in the spotlight on Wednesday after the company reported upbeat ...

Thermo Fisher Scientific (TMO) reported $10.36 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 0.2%. EPS of $5.15 for the same period compares to $5.11 a ...

Thermo Fisher kicked off 2025 with strong Q1 results, banking $10.36 billion in revenue and flexing its R&D muscles. CEO Marc ...